Recent Advances in the Development and Utilization of Nanoparticles for the Management of Malignant Solid Tumors DOI Open Access

Dhanashri D Chavan,

Rohit R. Bhosale, Vandana M Thorat

et al.

Cureus, Journal Year: 2024, Volume and Issue: unknown

Published: Sept. 27, 2024

The purpose of nanotechnology-based drug delivery systems or novel is to improve the effectiveness therapy, and their promising properties have led increasing significance in management cancer. researchers primarily focused on designing nanocarriers, like nanoparticles (NPs), that can effectively deliver drugs target cells respond specifically conditions particular Whether passive active targeting, these nanocarriers therapeutic cargoes tumor site release from systems. this study provide recent scientific literature key findings as well community medical pharmaceutical domains by reporting current advancements development NPs for treatment different malignant solid tumors, such colorectal, pancreatic, prostate, cervical

Language: Английский

Napabucasin deactivates STAT3 and promotes mitoxantrone-mediated cGAS-STING activation for hepatocellular carcinoma chemo-immunotherapy DOI
Lingzhi Wang, Shengnan Bi, Zhuo Li

et al.

Biomaterials, Journal Year: 2024, Volume and Issue: 313, P. 122766 - 122766

Published: Aug. 22, 2024

Language: Английский

Citations

8
Recent Advances in the Development and Utilization of Nanoparticles for the Management of Malignant Solid Tumors DOI Open Access

Dhanashri D Chavan,

Rohit R. Bhosale, Vandana M Thorat

et al.

Cureus, Journal Year: 2024, Volume and Issue: unknown

Published: Sept. 27, 2024

The purpose of nanotechnology-based drug delivery systems or novel is to improve the effectiveness therapy, and their promising properties have led increasing significance in management cancer. researchers primarily focused on designing nanocarriers, like nanoparticles (NPs), that can effectively deliver drugs target cells respond specifically conditions particular Whether passive active targeting, these nanocarriers therapeutic cargoes tumor site release from systems. this study provide recent scientific literature key findings as well community medical pharmaceutical domains by reporting current advancements development NPs for treatment different malignant solid tumors, such colorectal, pancreatic, prostate, cervical

Language: Английский

Citations

0